Earnings History Data for AcelRx Pharmaceuticals, Inc. (ACRX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of pain. The Company product candidates comprises: ARX-01 or the Sufentanil NanoTab PCA System; ARX-02 or the Sufentanil NanoTab BTP Management System; and ARX-03 or the Sufentanil/Triazolam NanoTab which are in their development stage. Its product ARX-01 is focused on acute post-operative pain, ARX-02 is focused on the treatment of cancer breakthrough pain and ARX-03 is focused on providing mild sedation, anxiety reduction, and pain relief to patients undergoing painful procedures in a physician's office. AcelRx Pharmaceuticals, Inc. is headquartered in Redwood City, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
16-08-2021 AH 4:00 PM ET
(Aug 16)
ACRX AcelRx Pharmaceuticals, Inc. 147.69 -0.08 -0.08 -0.08 AcelRx Pharmaceuticals EPS in-line, misses on revenue
[8/16/2021 4:02 PM]
0.9199 -0.20 
(-17.87%)
1.09 -0.03 
(-2.68%)
0.75 - 2.94 8,192,387 1,060,000 302,301
17-05-2021 AH 4:00 PM ET
(May 17)
ACRX AcelRx Pharmaceuticals, Inc. 135.78 -0.08 -0.08 -0.20 AcelRx Pharmaceuticals EPS in-line, misses on revenue
[5/17/2021 4:03 PM]
1.29 0.12 
(9.75%)
1.17 -0.01 
(-0.85%)
1.01 - 2.94 6,319,676 1,680,000 62,615
15-03-2021 AH 4:05 PM ET
(Mar 15)
ACRX AcelRx Pharmaceuticals, Inc. 198.03 -0.10 -0.12 -0.18 AcelRx Pharmaceuticals EPS in-line, misses on revenue
[3/15/2021 4:05 PM]
1.84 -0.34 
(-15.37%)
1.95 -0.23 
(-10.55%)
0.70 - 2.94 6,240,940 3,746,253 271,444
05-11-2020 AH 4:00 PM ET
(Nov 5)
ACRX AcelRx Pharmaceuticals, Inc. 164.39 -0.10 -0.07 -0.16 AcelRx Pharmaceuticals EPS misses by $0.02, misses on revenue
[11/5/2020 4:16 PM]
1.45 -0.42 
(-22.46%)
1.56 -0.31 
(-16.58%)
0.70 - 2.50 3,654,677 1,107,109 83,313
10-08-2020 AH 4:00 PM ET
(Aug 10)
ACRX AcelRx Pharmaceuticals, Inc. 94.49 -0.08 -0.14 -0.16 AcelRx Pharmaceuticals EPS beats by $0.06, beats on revenue
[8/10/2020 4:05 PM]
1.27 -0.10 
(-7.61%)
1.30 -0.08 
(-5.80%)
0.70 - 2.80 1,004,660 1,201,452 100,318